SITAWAR-50

Sitawar-50 contains Sitagliptin 50 mg, a DPP-4 inhibitor used in the management of Type 2 Diabetes Mellitus. It helps improve blood sugar control by supporting the body’s natural incretin hormones, which play an important role in insulin regulation after meals.The medicine helps the body release insulin when blood sugar levels rise and also helps reduce excess glucose production from the liver. This balanced mechanism supports better day-to-day glycemic control as part of an overall diabetes management plan that includes diet, exercise, and lifestyle modification.The 50 mg strength is often considered in patients who may require dose adjustment based on kidney function and clinical evaluation by the treating physician.

How Does Sitawar-50 Work?

• Sitagliptin works by blocking the DPP-4 enzyme, which helps increase the activity of natural incretin hormones in the body.
• These hormones help stimulate insulin release after meals when blood glucose levels are elevated.
• It also helps reduce excess glucose production by the liver, supporting better blood sugar regulation throughout the day.
• The medicine works in a glucose-dependent manner, meaning it mainly supports insulin release when blood sugar levels are high.
• This mechanism helps support effective glycemic management with a comparatively lower risk of hypoglycemia when used appropriately under medical supervision.

Clinical Benefits

• Helps support effective control of blood sugar levels in adults with Type 2 Diabetes Mellitus.
• Supports improvement in post-meal as well as fasting blood glucose management.
• May help support long-term HbA1c control when combined with proper diet and regular exercise.
• Generally considered weight-neutral in many patients during therapy.
• The 50 mg dose may be considered in patients requiring dose adjustment based on renal function assessment by the physician.
• Convenient once-daily dosing helps improve treatment adherence and patient convenience.

Dosage & Administration

Sitawar-50 should be taken strictly as directed by the physician. The dosage may vary depending on the patient’s blood glucose levels, kidney function, clinical condition, and response to therapy. Patients are advised to continue regular blood sugar monitoring, maintain a balanced diet, and follow an active lifestyle during treatment.

Disclaimer

To be used under medical supervision only. The information provided is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.